|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1201 F STREET, NW, #1000 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Winston-Salem |
State | NC |
Zip Code | 27101 |
Country | USA |
|
5. Senate ID# 33204-12
|
||||||||
|
6. House ID# 322070000
|
||||||||
| TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Richard L. Haselwood |
Date | 4/20/2020 4:03:22 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
H.R. 293, Youth Vaping Prevention Act
S. 655/H.R. 1498, SAFE Kids Act
S. 1965/H.R. 1642, Combatting Illicit Trade in Tobacco Products Act
S. 916/H.R. 1897, MOMMAS Act; provisions related to the taxation of tobacco products
H.R. 2084, Stopping Consumption of Tobacco by Teens (SCOTT) Act
S. 1048/H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act
H.R. 2339, Reversing the Youth Tobacco Epidemic Act
H.R. 2726, Banning Smoking on Amtrak Act
S. 1823/H.R. 3229, Children Dont Belong on Tobacco Farms Act
S. 1253/H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act
S. 1832/H.R. 4019, Smoke-Free Schools Act
H.R. 4249, Stop Vaping Ads Act
S. 2517/H.R. 4425, Tobacco Tax Parity Act/Quell Underage Inhaling of Toxic Substances (QUITS) Act
H.R. 4624, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act
H.R. 4742, Imposition of Tax on Nicotine for Use in Vapor Act
H.R. 5005, Prevent Vape Use Act
S. 3096/H.R. 5482, PREVENT (Providing Resources to End the Vaping Epidemic Now for Teenagers) Act
S. 3223/H.R. 5721, Resources to Prevent Youth Vaping Act
S. 3263/H.R. 5845, Break Free from Plastic Pollution Act
H.R. 5963, E-Cigarette Oversight and Accountability Act
S. 616, E-Cigarette Youth Protection Act
S. 1258/H.R. 2411, Tobacco to 21 Act
S. 1541, Tobacco-Free Youth Act
S. 1895, Lower Health Care Costs Act
S. 2463, E-Cigarette Tax Parity Act
S. 2519, Ending New Nicotine Dependencies (ENND) Act
S. 2536, E-Cigarette Device Standards Act
S. 2550, No Tax Subsidies for E-Cigarette and Tobacco Ads Act
Implementation of P.L. 111-31, the Tobacco Control Act
Issues surrounding FDA Premarket Tobacco Product Applications and Modified Risk Tobacco Product compliance policies
Issues surrounding taxation of tobacco products
January 2020 FDA guidance on flavors in vapor products
Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act
January 2020 FDA guidance on flavors in vapor products
FDA proposed rule concerning N-Nitrosonornicotine Levels in Smokeless Tobacco Products
ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565
Draft Guidance for Certain Marketed Tobacco Products, Docket No. FDA-2018-D-3244-0001
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
LaKeitha |
Anderson |
|
|
|
Cara |
Moon |
|
|
|
Flora |
Okereke |
|
|
|
Richard |
Haselwood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
As the ultimate parent entity of RAI Services Company, British American Tobacco p.l.c., disclosed on the LD-1, has an interest in the issues above.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Issues surrounding prevention of illicit tobacco, tariffs, duty and customs.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
LaKeitha |
Anderson |
|
|
|
Richard |
Haselwood |
|
|
|
Cara |
Moon |
|
|
|
Flora |
Okereke |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
As the ultimate parent entity of RAI Services Company, British American Tobacco p.l.c., disclosed on the LD-1, has an interest in the issues above.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 1865, the Further Consolidated Appropriations Act; provisions related to increasing the minimum age of purchase for tobacco products and FDA regulation of tobacco
H.R. 3164/S. 2522, FY2020 Agriculture, Rural Development, FDA and Related Agencies Act; provisions related to increasing the minimum age of purchase for tobacco products and FDA regulation of tobacco
H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act (CARES Act)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
LaKeitha |
Anderson |
|
|
|
Richard |
Haselwood |
|
|
|
Cara |
Moon |
|
|
|
Flora |
Okereke |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
As the ultimate parent entity of RAI Services Company, British American Tobacco p.l.c., disclosed on the LD-1, has an interest in the issues above.
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |